BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]

BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]

Larsen S, Butthongkomvog K, Manikhas A, et al. Breast Cancer: Targets and Therapy. 2014;6:179–189.On page 184 there is an error in Figure 3A. The error consists of a yellow bar at +16 days in the placebo group. Read the original article

Bibliographic Details
Main Authors: Larsen S, Butthongkomvong K, Manikhas A, Trishkina E, Poddubuskaya E, Matrosova M, Srimuninnimit V, Lindkær-Jensen S
Format: Article
Language:English
Published: Dove Medical Press 2015-06-01
Series:Breast Cancer : Targets and Therapy
Online Access:http://www.dovepress.com/corrigendum-bp-c1-in-the-treatment-of-patients-with-stage-iv-bre-peer-reviewed-article-BCTT

Internet

http://www.dovepress.com/corrigendum-bp-c1-in-the-treatment-of-patients-with-stage-iv-bre-peer-reviewed-article-BCTT

Similar Items